Browne L Daniel

CEO and President at Revance Therapeutics, Inc.

Sold, on record
$4.2M
Dollars the filings state
Form 4 sales
14
Latest Mar 18, 2019
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Revance Therapeutics, Inc.Plan not stated
    Aug 23 2017

    Sold 22,800 shares at $22.76 ($519k)

    Browne L Daniel, CEO and President

    Sold 12.7% of holdings ($4.1M position)156,050 shares left1.9x usual sizeFiling

  2. 2 Form 4 sale Revance Therapeutics, Inc.Plan not stated
    Sep 20 +28 days

    Sold 7,600 shares at $23.58 ($179k)

    Browne L Daniel, CEO and President

    Sold 4.9% of holdings ($3.7M position)148,450 shares left0.6x usual sizeFiling

  3. 3 Form 4 sale Revance Therapeutics, Inc.Plan not stated
    Oct 18 +28 days

    Sold 7,662 shares at $26.16 ($200k)

    Browne L Daniel, CEO and President

    Sold 5.2% of holdings ($3.9M position)140,788 shares left0.6x usual sizeFiling

  4. 4 Form 4 sale Revance Therapeutics, Inc.Plan not stated
    Nov 22 +35 days

    Sold 7,600 shares at $24.94 ($190k)

    Browne L Daniel, CEO and President

    Sold 5.4% of holdings ($3.5M position)133,188 shares left0.6x usual sizeFiling

  5. 5 Form 4 sale Revance Therapeutics, Inc.Plan not stated
    Mar 7 +105 days

    Sold 27,283 shares at $31.43 ($858k)

    Browne L Daniel, CEO and President

    Sold 17.2% of holdings ($5M position)131,208 shares left2.3x usual sizeFiling

  6. 6 Form 4 sale Revance Therapeutics, Inc.Plan not stated
    Mar 16 +9 days

    Sold 6,452 shares at $31.64 ($204k)

    Browne L Daniel, CEO and President

    Sold 4.3% of holdings ($4.7M position)141,875 shares left0.5x usual sizeFiling

  7. 7 Form 4 sale Revance Therapeutics, Inc.Plan not stated
    Feb 19 +340 days

    Sold 5,446 shares at $17.68 ($96k)

    Browne L Daniel, CEO and President

    Sold 3.1% of holdings ($3.1M position)168,943 shares left0.6x usual sizeFiling

  8. 8 Form 4 sale Revance Therapeutics, Inc.Plan not stated
    Mar 18 +27 days

    Sold 11,613 shares at $15.51 ($180k)

    Browne L Daniel, CEO and President

    Sold 7.1% of holdings ($2.5M position)151,193 shares left1.5x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (14)

Form 144 notices and Form 4 sales by Browne L Daniel
Source
Mar 18, 2019Revance Therapeutics, Inc.CEO and PresidentForm 4 sale11,613$180k7.1%Plan not statedSEC
Feb 19, 2019Revance Therapeutics, Inc.CEO and PresidentForm 4 sale5,446$96k3.1%Plan not statedSEC
Mar 16, 2018Revance Therapeutics, Inc.CEO and PresidentForm 4 sale6,452$204k4.3%Plan not statedSEC
Mar 7, 2018Revance Therapeutics, Inc.CEO and PresidentForm 4 sale27,283$858k17.2%Plan not statedSEC
Nov 22, 2017Revance Therapeutics, Inc.CEO and PresidentForm 4 sale7,600$190k5.4%Plan not statedSEC
Oct 18, 2017Revance Therapeutics, Inc.CEO and PresidentForm 4 sale7,662$200k5.2%Plan not statedSEC
Sep 20, 2017Revance Therapeutics, Inc.CEO and PresidentForm 4 sale7,600$179k4.9%Plan not statedSEC
Aug 23, 2017Revance Therapeutics, Inc.CEO and PresidentForm 4 sale22,800$519k12.7%Plan not statedSEC
May 24, 2017Revance Therapeutics, Inc.CEO and PresidentForm 4 sale32,000$649k16.3%Plan not statedSEC
Feb 22, 2017Revance Therapeutics, Inc.CEO and PresidentForm 4 sale11,037$227k5.2%Plan not statedSEC
Jan 25, 2017Revance Therapeutics, Inc.CEO and PresidentForm 4 sale12,000$237k6.1%Plan not statedSEC
Dec 28, 2016Revance Therapeutics, Inc.CEO and PresidentForm 4 sale12,000$251k5.8%Plan not statedSEC
Nov 25, 2016Revance Therapeutics, Inc.CEO and PresidentForm 4 sale12,000$215k5.5%Plan not statedSEC
Oct 26, 2016Revance Therapeutics, Inc.CEO and PresidentForm 4 sale12,000$178k5.2%Plan not statedSEC